SVB Wealth’s Transmedics TMDX Stock Holding History

SVB Wealth’s Portfolio TMDX Stock Details TMDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-168	Closed	-$11.3K	–	1525
2025 Q1	$11.3K	Buy	+168	New	+$11.6K	﹤0.01%	863

Other funds holding TMDX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SVB Wealth's TMDX Position: Q2 2025 in Review

SVB Wealth sold out of Transmedics (TMDX) in Q2 2025, closing a stake of 168 shares — an estimated $11.3K sold.

SVB Wealth first reported a position in TMDX in Q1 2025 and held it in 1 quarter. The position peaked at $11.3K in Q1 2025. 368 funds tracked by Wall St. Rank hold TMDX as of Q2 2025.

SVB Wealth reported no remaining Transmedics position as of Q2 2025 after selling out during the quarter.
SVB Wealth sold 168 Transmedics shares in Q2 2025, an estimated $11.3K.
SVB Wealth first reported a position in Transmedics in Q1 2025 and held it in 1 quarter.
SVB Wealth's Transmedics position peaked at $11.3K in Q1 2025.
368 funds tracked by Wall St. Rank held Transmedics as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.